Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress HPK Q1 2026 Earnings Significant earnings miss accompanied by stock rally CRIS Q1 2026 Earnings WiderThanExpected Loss on No Reported Revenue Stock Rises Despite Miss RNAC Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline PLMR Q1 2026 Earnings EPS Surpasses Estimates by 301 Amid Modest Stock Pullback MMI Q1 2026 Earnings Loss Wider Than Expected as Revenue Remains Unclear